中文 | English
Return
Total: 5594 , 1/560
Show Home Prev Next End page: GO
Author:(Shu-Shu WANG)

1.Anti-thyroid drugs—first choice for Graves' disease

Shu WANG

Chinese Journal of Practical Internal Medicine 2003;0(01):-

2.Analysis of Cause-related Marketing Strategy in Pharmaceutical Industry

Shuling WANG ; Shu WANG

China Pharmacy 2005;0(16):-

3.Efficacy of low intensity warfarin anticoagulation therapy in elderly patients after heart valve replacement

Shu CHEN ; Duanchao SHU ; Zongshe WANG

Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2017;19(1):35-37

5.CSI:New Factor for Marketing Competition of Pharmaceutical Enterprises

Shu WANG ; Wenzhan YANG

China Pharmacy 1991;0(01):-

6.Thinking About the Packaging of Pharmaceutical Products and the Safety of Drug Use

Wenzhan YANG ; Shu WANG

China Pharmacy 1991;0(06):-

7.The measurement of convergence angles of the fixed denture

Shu JIANG ; Zhongyi WANG

Journal of Practical Stomatology 2001;17(2):138-140

8.Structure features of reactive oxygen species and NADPH oxidases and their roles in cardiomyocyte proliferation and death

Miao LI ; Shu WANG

Chinese Journal of Tissue Engineering Research 2006;10(45):220-224

9.Treatment of Lumbar Disc Herniation with Intervertbral Disc Version Operation

Shu HUANG ; Weigang WANG

International Journal of Traditional Chinese Medicine 2009;31(3):209-211

10.Immunoregulation of radix tanshinone on isolated-lung preservation

Yongjian WANG ; Ping SHU

Chinese Journal of Primary Medicine and Pharmacy 2008;15(5):705-706

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5594 , 1/560 Show Home Prev Next End page: GO